By Michael Lipkin ( January 21, 2014, 9:23 PM EST) -- AstraZeneca AB on Tuesday asked for a full rehearing before the Federal Circuit in its ongoing efforts to block Hanmi USA Inc.'s generic version of acid reflux drug Nexium, arguing that a Federal Circuit panel disregarded precedent in upholding a lower court's claim construction....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.